ADRMD (Adherium) Valuation Rank


ADRMD Adherium Ltd ADRMD
8 GF Score
Price $0.30
GF Value $0.53
! 8 Warning Signs
View Full Analysis

What is Adherium Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Adherium Valuation Rank Related Terms

ADRMD
8GF Score
Adherium Ltd ADRMD
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Adherium (ADRMD) Overvalued in 2026?

Based on GuruFocus' analysis, Adherium stock appears to be undervalued. The current stock price of $0.30 is trading 43.4% below its estimated GF Value™ of $0.53.

Key valuation signals for ADRMD:

  • Valuation Rank:
  • GF Value™: $0.53 vs. price of $0.30 (43.4% below fair value)
  • GF Score™: 8/100 with 8 warning signs

No single metric tells the full story. See the ADRMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Adherium Business Description

Other Exchanges ADR:Australia
Address 447 Collins Street, Level 5, Melbourne, VIC, AUS, 3000
Adherium Ltd is engaged in the development, manufacture, and supply of its Hailie digital health technologies that address sub-optimal medication use and improve health outcomes in chronic disease. It is an international Respiratory eHealth company focused on patient medication adherence, remote monitoring, and data management solutions for patients, payers, and providers. Its geographically segments include New Zealand and Australia, Europe, North America, and Asia. The majority of its revenue comes from Europe.
8GF Score

Get the complete analysis for ADRMD

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.30
Price
$0.53
GF Value